Drug Profile
Research programme: cannabinoid CB1 receptor antagonists - Solvay
Latest Information Update: 05 Mar 2010
Price :
$50
*
At a glance
- Originator Solvay
- Class Pyrazoles; Sulfonamides
- Mechanism of Action Cannabinoid receptor CB1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity; Psychotic disorders
Most Recent Events
- 23 Jan 2007 Preclinical development for obesity is ongoing
- 18 Sep 2002 Preclinical trials in Obesity in Netherlands (unspecified route)
- 18 Sep 2002 Preclinical trials in Psychotic disorders in Netherlands (unspecified route)